ABVC icon

ABVC BioPharma

10 hedge funds and large institutions have $305K invested in ABVC BioPharma in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
5
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Geode Capital Management
1
Geode Capital Management
Massachusetts
$111K 104,482 +25,197 +32%
XT
2
XTX Topco
Cayman Islands
$64.1K 60,439 +26,034 +76%
Vanguard Group
3
Vanguard Group
Pennsylvania
$49.8K 46,947
UBS Group
4
UBS Group
Switzerland
$30.7K 29,003 +28,993 +289,930%
Northern Trust
5
Northern Trust
Illinois
$20.3K 19,135
State Street
6
State Street
Massachusetts
$13.7K 12,900
TSS
7
Two Sigma Securities
New York
$12.2K 11,470 -1,123 -9%
TRCT
8
Tower Research Capital (TRC)
New York
$2.73K 2,576 +13 +0.5%
SS
9
SBI Securities
Japan
$488 460 -202 -31%
Bank of America
10
Bank of America
North Carolina
$90 85 +4 +5%
APP
11
Avantax Planning Partners
Iowa
-143,968 Closed
Citadel Advisors
12
Citadel Advisors
Florida
-40,743 Closed
VF
13
Virtu Financial
New York
-15,935 Closed
CFGS
14
Concourse Financial Group Securities
Alabama